刘永蕊,刘静蕾,唐国栋.PDCD5基因与非小细胞肺癌的研究进展[J].中国肿瘤,2015,24(4):302-306.
PDCD5基因与非小细胞肺癌的研究进展
Research Progress of PDCD5 in Non-small Cell Lung Cancer
投稿时间:2014-09-10  
DOI:10.11735/j.issn.1004-0242.2015.04.A011
中文关键词:  PDCD5  非小细胞肺癌  文献分析
英文关键词:PDCD5  non-small cell lung cancer  literature review
基金项目:
作者单位
刘永蕊 哈尔滨医科大学附属肿瘤医院 
刘静蕾 哈尔滨医科大学附属肿瘤医院 
唐国栋 哈尔滨医科大学附属肿瘤医院 
摘要点击次数: 2045
全文下载次数: 930
中文摘要:
      摘 要:程序性细胞死亡分子5(programmed cell death 5,PDCD5)作为一种重要的凋亡正调控分子,在许多疾病的发生发展过程中起着重要作用。PDCD5在肺癌、结直肠癌、卵巢癌、乳腺癌等多种恶性肿瘤细胞株、患者血清及其肿瘤组织中均有表达水平下降,而在骨关节炎、狼疮性肾炎、支气管哮喘等自身免疫性疾病中表达上调。大量的临床实验研究涉及了PDCD5与非小细胞肺癌之间的关系,全文就目前PDCD5与非小细胞肺癌的研究进展作一综述。
英文摘要:
      Abstract:Programmed cell death 5(PDCD5) is an important molecule related to apoptosis and plays important roles in the process of many diseases.PDCD5 was under-expression in a variety of lung cancer,colorectal cancer,ovarian cancer,breast cancer and other malignant tumor cells,serum and tumor tissue. However,PDCD5 was overexpressed in autoimmune disease,such as osteoarthritis,lupus nephritis,bronchial asthma. A large quantity of clinical experiments studies concern the relationship between PDCD5 and non-small cell lung cancer. The current research progress of PDCD5 and non-small cell lung cancer were reviewed in this paper.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器